ACC 2017Acute Coronary Syndrome GEMINI-ACS-1: Bleeding with low-dose rivaroxaban versus aspirin after ACS Last updated: April 22, 2018 4:13 pm Medhat Abdelwahed, M.D. Share 0 Min Read SHARE http://cardiologynownews.org/wp-content/uploads/2017/12/1961-1929.mp4 TAGGED:ACC 2017acute coronary syndromeConferenceRivaroxaban Share This Article Facebook Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment. Archives Archives Select Month November 2025 September 2025 August 2025 April 2025 March 2025 November 2024 October 2024 September 2024 August 2024 June 2024 April 2024 November 2023 August 2023 March 2023 November 2022 September 2022 August 2022 April 2022 November 2021 October 2021 September 2021 August 2021 May 2021 March 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 December 2018 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 April 2018 March 2018 February 2018 January 2018 December 2017 November 2017 August 2017 May 2017 March 2017 Search Search for: Categories ACC 2019 ACC 2020 ACC 2021 ACC 2022 ACC 2024 ACC 2025 Acute Coronary Syndrome ADA 2024 AHA 2019 AHA 2022 AHA 2023 AHA 2024 AHA 2025 Anti-hypertensives Arrhythmia and Electrophysiology Atherosclerotic Cardiovascular Disease Atrial Fibrillation Biomarkers CABG Cardiac Arrest Cardio-Immuno-Oncology Cardiogenic shock Cardiomyopathies Cardiovascular Imaging Cardiovascular Prevention Cardiovascular Surgery Cerebrovascular Disease Clinical Trials Conferences ACC 2017 ACC 2018 ACC 2023 AHA 2017 AHA 2021 ESC 2017 ESC 2018 ESC 2021 ESC 2023 ESC 2024 ESC 2025 SCAI 2017 SCAI 2018 TCT 2017 TCT 2018 TCT 2019 TCT 2021 TCT 2022 Coronary Artery Disease Covid-19 Diabetes mellitus Endocarditis Entertainment ESC 2019 ESC 2021 ESC 2022 Fashion FDA General Cardiology Health Heart Failure Heart trasnplant Hepatitis C Hypertension Imaging Interventional Cardiology Lipid Lowering Therapy Microvascular dysfunction Myocardial Infarction News NT-ProBNP Out Of Hospital Cardiac Arrest Peripheral Vascular Disease Pharmaceutical industry Podcasts policy Politics Prevention SARS-CoV-2 Science Slides Sonothrombolysis Statins Stroke Structural Heart Disease Sudden Cardiac Death Syncope TCT 2019 TCT 2024 Technology Thrombosis Transthyretin cardiomyopathy Travel Uncategorized Valvular Heart Disease Vascular Medicine Vasospastic angina Videos Meta Log in Entries feed Comments feed WordPress.org
